Autopsy findings and pattern of mortality in Nigerian sickle cell disease patients

Autopsy findings and pattern of mortality in Nigerian sickle cell disease patients

 

Gabriel Olabiyi Ogun^1,&, Henry Ebili¹, Taiwo Racheal Kotila²

 

¹Department of Pathology, College of Medicine, University of Ibadan, University College Hospital, Ibadan, Nigeria, ²Department of Hematology, College of Medicine, University of Ibadan, University College Hospital, Ibadan, Nigeria

 

 

^&Corresponding author
Gabriel Olabiyi Ogun, Department of Pathology, University College Hospital, Ibadan, Nigeria

 

 

 

 

Sickle cell disease (SCD) describes the conditions in which the haemoglobin (Hb)S gene is inherited with another abnormal β chain gene, which include the homozygote state (HbSS) and the double heterozygote state (HbSC or HbS- β thalassaemia). The homozygote state also known as sickle cell anemia (SCA) is the commonest variant and has the severest clinical manifestations of any of the SCD variants. The heterozygote state (sickle cell trait or HbAS) is usually normal phenotypically. Sickle cell disease is the commonest haemoglobinopathy and single gene disorder in black Africans. In the Nigerian population, carrier rate for the trait (HbAS) is about 25% while 2-3% suffers from SCA [1]. Diagnosis of SCD in Nigeria is by haemoglobin electrophoresis at alkaline pH alone, so patients are either diagnosed as HbS or HbS+C and a report is stuck on the case file of the patients. Such reports may however be missing in some patients if the case file becomes voluminous and a new file is opened. Autopsies are performed at the request of the Haematologist after the demise of a patient in the hospital after obtaining consent from the relatives and rarely when a patient is brought in dead after having died at home or while in transit to the hospital. We sought to investigate the pattern and causes of mortality in SCD at our centre, with emphasis on the causes of death among SCD patients at our hospital. We believe that the findings of the study would help direct clinical management to focus attention on these specific causes of death, which with good management and policy may improve morbidity and mortality. This will be by the way of aiding clinical preparedness, streamlining patient counseling and enabling preventive therapies. In addition, it will add to the existing epidemiological data, knowledge of the disease and possibly the pathogenesis of the disease.

 

 

This is a retrospective study of SCD patients who died between January 1991 and December 2008 and had autopsy examination to confirm the cause of death at the Department of Pathology, University College Hospital, Ibadan. The clinical history/data, including the age, gender, Hb genotype, and the major autopsy findings and cause of death were obtained for each patient from the complete autopsy reports that included histopathological examination. Patients were included in the review if they were referred from the Haematology department as having SCD and this was corroborated by the report of the electrophoresis in the case file. The immediate and specific (diseases or conditions directly leading to death) cause of death were recorded according to the internationally accepted/ World Health Organization (WHO) medical certification of cause of death. Multiple or joint causes of death was entertained. A broad classification of the cause of death under the following rubrics was done- infections, thromboembolism, Severe Anaemia with Cardiac failure, Acute Hepatospleenic sequestration, Aspiration pneumonitis, Intracranial haemorrhage and Massive Erosive gastritis and duodenitis. This study was conducted in compliance with the guidelines of the Helsinki declaration on biomedical research in human subjects. Confidentiality of the identity of the patients and personal health information was maintained.

 

 

A total of 52 cases were seen in the seventeen year period out of which 48 had electrophoresis report in the clinical notes but the report was missing in four. Forty (83.3%) had SCA while 8(16.6%) were Hb S+C. The mean age was 21.0 years with a range of 1-47 years. HbS+C and male patients were slightly older 24 Vs 21 years and 22.7 Vs 19.4 years respectively. Peak mortality occured in the 2nd and 3rd decades of life but with equal sex distribution, more deaths occurred however in the female child in the first decade of life (Figure 1). Infections and thromboembolic phenomenon were the major cause of death, contributing to demise in 78% and 37% of cases respectively (Table 1). This was followed by severe anemia contributed as cause of death in about 31% of cases, but deaths arising from anaemia was caused by sequestration into either or both the liver or spleen in a third of such patients (Table 1). Infections of the respiratory system affected more than half of the patients (53.8%, Table 2), thromboembolic phenomenon also affected the respiratory system in half of the patients (Table 3) making acute chest syndrome the leading cause of death.

 

 

The finding of 52 deaths in a 17 year period does not translate to a low death rate in the Nigerian SCD patients, since the recorded low death rate may be due to the fact that family members often do not consent to autopsy because of religious and social reasons [2]. Secondly, not all deaths are reported, especially when it occurs in the home setting and for a disease condition that is emotionally and financially tasking for the family. This is especially so in early childhood when children will succumb to the illness as a result of infection or anaemia before getting to the hospital.

 

The mean age at death of 21 years is similar to the mean age of 22 years obtained from a clinical review of sickle cell disease patients about the same time in our centre [3]. This would suggest that the median survival of the Nigerian SCD patient is much lower than that of Jamaican or USA patients [4]. The mean age at death for HbSS and HbSC, of our patients is comparable to the findings of Manci et al. [5] who found a mean age at death of 20.7 years among HbSS patients and 25 years among HbSC patients from across several centres in the United States. However, this mean age at demise are much lower than what has been reported in other series in the United States [6,7], Jamaica [8], France and England [9] where the age at death were between 32 years and 45 years for SCA and up to 68 years for HbS+C. The higher survival in those studies could be attributed to easy access of SCD patients to health care and health education in the locales where these studies were done. Infection and thromboembolic events are leading cause of death in SCD patients as shown by other studies [6-10]. These were categorized as acute chest syndrome as done by Thomas et al and Platt et al. [6,8]. The study from England and France however reported vaso-occlusion related causes as the most common cause of death but this was followed closely by infection [9]. Meningitis featured prominently as an infectious cause of death in this study, being responsible for 13.2% (7 out of 53) cases of deaths among our patients. Meningitis was similarly a major cause of death in other series by Thomas et al and Perronne et al where it was the commonest infective cause of death [8,9].

 

SCD patients are more prone to infections because of autosplenectomy that occurs as a result of repeated infarction of the organ thus leading to the loss and inability to fight infection. Additionally, SCD patients have defective alternative pathway of complement activation and reduced ability of neutrophils to kill pathogenic organisms which makes them especially prone to infection by encapsulated organisms. Common bacterial organisms that have been documented to cause infection in SCD patients in our environment include Salmonella typhi, E. coli, Staphylococcus Aureus, Haemophillus influenza and Klebsiella species [11,12], while Infection caused by Streptococcus pneumonia which have been reported by others have not been reported among SCD patients in our locale [11-13]. The high prevalence of infections by Haemophilus Influenza and Pneumococcus species in patients with SCD, is the reason why patients in the UK and USA are placed on prophylaxis and vaccinated against these organisms. The introduction of bacterial prophylaxis for SCD patients in Nigeria may therefore reduce the mortality rate especially in early childhood due to infections.

 

Another important cause of death in our cohort is severe anaemia associated with cardiac failure, playing a significant role as cause of death in 21% of cases. Cardiac failure was also an important mechanism of death in other studies [5-7,9]. Other causes of cardiac failure in SCD patients may include myocardial infarction, arrhythmias, and cardiomyopathy [7] but these did not feature in our patients possibly because they do not live long enough to experience such complications. Organ sequestration, a spontaneous pooling of blood in solid and spongy viscera occur most commonly in the spleen, but also in the liver and lungs in SCD patients. Its pathogenesis is unknown but it usually follows or occurs concomitantly with acute viral infections, pain crisis, bacteraemia and stroke. It causes cardiovascular collapse and it is not an uncommon cause of death in this group of patients. In this study hepatosplenic sequestration was a cause of death in 9.6% of our patients, being the 4th commonest cause of death. Thomas et al and Pafrey et al found organ sequestration to be the second commonest cause of death (12% in both studies) [8,10].

 

 

This study has illustrated that the commonest cause of death in the SCD patients in the Nigerian SCD patient is acute chest syndrome which may present either as infections or thromboembolism in the respiratory system. The use of bacterial prophylaxis early in childhood is expected to reduce early mortality and thus improve the life expectancy of these patients.

 

 

The authors declare no competing interests.

 

 

Gabriel Olabiyi Ogun conceived the idea of the study. Gabriel Olabiyi Ogun and Henry Ebili collated and analysed the data. All authors were involved in all drafts of the manuscript and contributed to the manuscript.

 

 

Table 1: Broad classification of the causes of death

Table 2: Systemic localization of infections causing death

Table 3: Organ/system location of thrombo-embolic phenomena

Figure 1: Age group and gender distribution of patients

 

 

1. Omotade OO, Kayode CM, Falade SL, Ikpeme S, Adeyemo AA, Akinkugbe FM. Routine screening for sickle cell haemoglobinopathy by electrophoresis in an infant welfare clinic. West Afr J Med.1998;17(2):91-94. PubMed | Google Scholar


2. Oluwasola OA, Fawole OI, Otegbayo AJ, Ogun GO, et al. The Autopsy: Knowledge, Attitude and perceptions of Doctors and relatives of deceased. Arch Pathol Lab Med. 2009; 133(1):78-8. PubMed | Google Scholar


3. Kotila TR, Shokunbi WA. Survival advantage in female patients with sickle cell anaemia. East Afr Med J. 2001;78(7):33-35. PubMed | Google Scholar


4. Serjeant GR. Mortality from sickle cell disease in Africa. BMJ. 2005; 330 (7489):433-43. PubMed | Google Scholar


5. Manci EA, Culberson DE, Yang Y-M, Gardner TM, Powell R, Haynes J,et al. Causes of death in sickle cell disease: an autopsy study. British J of Haematology. 2003;123(2):359-6. PubMed | Google Scholar


6. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease: Life expectancy and risk factors for early death. N Engl J Med. 1994; 330:1639-1644. PubMed | Google Scholar


7. Darbari DS, Kple-Faget P, Kwangyan J, Rana S, Castro O. Circumstances of death in adult sickle cell disease patients. Am J of Haematol. 2006; 81(11): 858-863. PubMed | Google Scholar


8. Thomas AN, Pattison C, Serjeant GR. Causes of death in sickle-cell disease in Jamaica. Br Med J. 1982; 285 (6342):633-635. PubMed | Google Scholar


9. Perronne V, Roberts-Harewood M, Bachir D, Roudot-Thoraval F, Delord J-M, Thuret I, et al. Pattern of mortality in sickle cell disease in adults in France and England. The Haematology Journal. 2002; 3(1):56-60. PubMed | Google Scholar


10. Parfrey NA, Moore W, Hutchins GM. Is pain crisis a cause of death in sickle cell disease? Am J ClinPathol. 1985; 84(2):209-212. PubMed | Google Scholar


11. Akuse, RM. Variation in the pattern of bacterial infection in patients with sickle cell disease requiring admission. Pediatr. 1996; 42(6):318-323. PubMed | Google Scholar


12. Okuonghae, HO, Nwankwo, MU and Offor, EC. Pattern of bacteraemia in febrile children with sickle cell anaemia. Ann Trop Paediatr. 1993; 13(1): 55-64. PubMed | Google Scholar


13. Serjeant GR, Ndugwa CM. Sickle cell disease in Uganda: a time for action. East African Medical Journal. 2003; 80(7): 384-387. PubMed | Google Scholar